BPI
DWTX icon

BFC Planning, Inc.’s Dogwood Therapeutics DWTX Stock Holding History

BFC Planning, Inc.’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32 Hold
20
– – ﹤0.01% 3387
2026
Q1 		$42 Hold
20
– – ﹤0.01% 2992
2025
Q4 		$83 Sell
20
-20
-50% -$118 ﹤0.01% 3105
2025
Q3 		$308 Hold
40
– – ﹤0.01% 2795
2025
Q2 		$191 Hold
40
– – ﹤0.01% 2607
2025
Q1 		$200 Hold
40
– – ﹤0.01% 2585
2024
Q4 		$100 Buy
+40
New +$132 ﹤0.01% 2543

Other funds holding DWTX

Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BFC Planning, Inc.'s DWTX Position: Q2 2026 in Review

BFC Planning, Inc. held its Dogwood Therapeutics (DWTX) position steady in Q2 2026 at 20 shares worth $32. The position accounts for ﹤0.01% of the portfolio, ranked #3387.

BFC Planning, Inc. first reported a position in DWTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $308 in Q3 2025. 16 funds tracked by Wall St. Rank hold DWTX as of Q2 2026.

  • BFC Planning, Inc. held 20 shares of Dogwood Therapeutics worth $32 as of Q2 2026.
  • BFC Planning, Inc. left its Dogwood Therapeutics share count unchanged in Q2 2026.
  • Dogwood Therapeutics made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #3387 holding.
  • BFC Planning, Inc. first reported a position in Dogwood Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • BFC Planning, Inc.'s Dogwood Therapeutics position peaked at $308 in Q3 2025.
  • 16 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.